Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma-Reference-Cited by-同舟云学术

Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma

Published:2006-02-01 Issue:3 Volume:106 Page:703-707
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bisogno Gianni,Riccardi Riccardo,Ruggiero Antonio,Arcamone Giampaolo,Prete Arcangelo,Surico Gianmarco,Provenzi Massimo,Bertolini Patrizia,Paolucci Paolo,Carli Modesto

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference10 articles.

1. Drug Evaluation: Oncologic, Endocrine & Metabolic: Irinotecan (CPT-11): Current status and perspectives

2. Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors

3. Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts

4. Direct Translation of a Protracted Irinotecan Schedule From a Xenograft Model to a Phase I Trial in Children

5. Irinotecan for Pediatric Solid Tumors: The Memorial Sloan-Kettering Experience

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Capacity of Drug-Metabolising Enzymes in Modulating the Therapeutic Efficacy of Drugs to Treat Rhabdomyosarcoma;Cancers;2024-02-29

2. The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma;BMC Cancer;2024-02-03

3. Current Role of Topoisomerase I Inhibitors for the Treatment of Mesenchymal Malignancies and Their Potential Future Use as Payload of Sarcoma-Specific Antibody-Drug Conjugates;Oncology Research and Treatment;2023-11-28

4. Longer versus Shorter Schedules of Vincristine, Irinotecan, and Temozolomide (VIT) for Relapsed or Refractory Ewing Sarcoma: A Randomized Controlled Phase 2 Trial;Clinical Cancer Research;2023-01-09

5. A potential alternative systemic treatment option for epithelioid sarcoma;2022-12-22